These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27053333)

  • 1. Clinicopathological Characteristics and Survival Outcomes in Invasive Papillary Carcinoma of the Breast: A SEER Population-Based Study.
    Zheng YZ; Hu X; Shao ZM
    Sci Rep; 2016 Apr; 6():24037. PubMed ID: 27053333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database.
    Chen S; Wang J; Yang L; Ji M; Chen S
    J BUON; 2021; 26(5):1991-2002. PubMed ID: 34761609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
    Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
    Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
    Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
    Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population-based study.
    Yang LP; Sun HF; Zhao Y; Chen MT; Zhang N; Jin W
    Cancer Med; 2017 Dec; 6(12):2867-2875. PubMed ID: 29131529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the Breast.
    Huang K; Appiah L; Mishra A; Bagaria SP; Gabriel ME; Misra S
    J Surg Res; 2021 May; 261():105-112. PubMed ID: 33422900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast: a large case study.
    Liu ZY; Liu N; Wang YH; Yang CC; Zhang J; Lv SH; Niu Y
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):77-84. PubMed ID: 22932921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma.
    Wong SM; Freedman RA; Sagara Y; Stamell EF; Desantis SD; Barry WT; Golshan M
    Cancer; 2015 Dec; 121(24):4333-40. PubMed ID: 26376021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database.
    Zhang N; Zhang H; Chen T; Yang Q
    Oncotarget; 2017 Apr; 8(15):24579-24592. PubMed ID: 28445946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
    Hassan Z; Boulos F; Abbas J; El Charif MH; Assi H; Sbaity E
    Breast Cancer Res Treat; 2020 Jul; 182(2):317-323. PubMed ID: 32462260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative prognostic analysis for triple-negative breast cancer with metaplastic and invasive ductal carcinoma.
    Li Y; Zhang N; Zhang H; Yang Q
    J Clin Pathol; 2019 Jun; 72(6):418-424. PubMed ID: 30872384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
    Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
    Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
    Nelson RA; Guye ML; Luu T; Lai LL
    Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
    Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
    Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
    Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
    Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.